Search

everythinglearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

These medications for BPH have known risks and may have new side effects.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Five FDA-approved drugs may help block COVID-19 virus entry.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.